Insights On Trial Design

1. Why Team Integration Makes Or Breaks Marketing Applications 4/10/2025

   True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.

2. Breaking Silos In Drug Development: The Power Of An Integrated Model 5/11/2026

   Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.

3. Optimizing The Path From First-In-Human To Proof-Of-Concept 2/23/2026

   By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

4. Challenges And New Approaches To Developing Clinical Evidence For Medical Devices 9/12/2024

   Learn about the challenges and new approaches to developing clinical evidence for medical devices, including decentralized trials, adaptive studies, in silico trials, and real-world evidence.

5. Does 'The Belmont Report' Provide Guidance For Patient Stipends? 12/5/2025

   Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.

6. Survey Says Mobile Nurse Visits Have A Place In Clinical Trials 1/28/2025

   Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.

7. Understanding Subjective Outcome Measures In HAP Studies 4/28/2026

   Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.

8. FDA Draft Guidance On Diversity Action Plan Requirements 10/24/2024

   Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.

9. Demonstrating IDS Value With Time-Based Metrics 6/10/2026

   Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

10. Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial? 5/28/2026

    Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.